Zaru L - Search Results

1

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.

Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ; REGENERATE Study Investigators. Younossi ZM, et al. Among authors: zaru l. Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5. Lancet. 2019. PMID: 31813633 Free article. Clinical Trial.

2

Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study.

Hosking D, Adami S, Felsenberg D, Andia JC, Välimäki M, Benhamou L, Reginster JY, Yacik C, Rybak-Feglin A, Petruschke RA, Zaru L, Santora AC. Hosking D, et al. Among authors: zaru l. Curr Med Res Opin. 2003;19(5):383-94. doi: 10.1185/030079903125002009. Curr Med Res Opin. 2003. PMID: 13678475 Clinical Trial.

3

Safety and Efficacy of Atazanavir Powder and Ritonavir in HIV-1-Infected Infants and Children From 3 Months to <11 Years of Age: The PRINCE-2 Study.

Cotton MF, Liberty A, Torres-Escobar I, Gonzalez-Tome MI, Lissens J, Zaru L, Klauck I, Cambilargiu D, Pikora C, Correll TA. Cotton MF, et al. Among authors: zaru l. Pediatr Infect Dis J. 2018 Jun;37(6):e149-e156. doi: 10.1097/INF.0000000000001856. Pediatr Infect Dis J. 2018. PMID: 29206747 Clinical Trial.

4

Pharmacokinetics and Pharmacodynamics of Atazanavir in HIV-1-Infected Children Treated With Atazanavir Powder and Ritonavir: Combined Analysis of the PRINCE-1 and -2 Studies.

Sevinsky H, Zaru L, Wang R, Xu X, Pikora C, Correll TA, Eley T. Sevinsky H, et al. Among authors: zaru l. Pediatr Infect Dis J. 2018 Jun;37(6):e157-e165. doi: 10.1097/INF.0000000000001855. Pediatr Infect Dis J. 2018. PMID: 29206748 Clinical Trial.

5

Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH.

Alkhouri N, LaCerte C, Edwards J, Poordad F, Lawitz E, Lee L, Karan S, Sawhney S, Erickson M, MacConell L, Zaru L, Chen J, Campagna J. Alkhouri N, et al. Among authors: zaru l. Liver Int. 2024 Apr;44(4):966-978. doi: 10.1111/liv.15816. Epub 2024 Jan 31. Liver Int. 2024. PMID: 38293761 Clinical Trial.

6

An integrated analysis of fecal microbiome and metabolomic features distinguish non-cirrhotic NASH from healthy control populations.

Carr RM, Li Y, Chau L, Friedman ES, Lee JJ, Adorini L, Erickson M, Zaru L, Shringarpure R, MacConell L, Bittinger K, Li H, Wu GD. Carr RM, et al. Among authors: zaru l. Hepatology. 2023 Dec 1;78(6):1843-1857. doi: 10.1097/HEP.0000000000000474. Epub 2023 May 25. Hepatology. 2023. PMID: 37222264

7

The Application of Gail Model to Predict the Risk of Developing Breast Cancer among Jordanian Women.

Abdel-Razeq H, Zaru L, Badheeb A, Hijjawi S. Abdel-Razeq H, et al. Among authors: zaru l. J Oncol. 2020 Feb 20;2020:9608910. doi: 10.1155/2020/9608910. eCollection 2020. J Oncol. 2020. PMID: 32148498 Free PMC article.

8

Perception and attitude of Jordanian physicians towards complementary and alternative medicine (CAM) use in oncology.

Al-Omari A, Al-Qudimat M, Abu Hmaidan A, Zaru L. Al-Omari A, et al. Among authors: zaru l. Complement Ther Clin Pract. 2013 May;19(2):70-6. doi: 10.1016/j.ctcp.2013.01.002. Epub 2013 Mar 7. Complement Ther Clin Pract. 2013. PMID: 23561063

9

Knowledge, attitudes and behavior regarding antibiotics use and misuse among adults in the community of Jordan. A pilot study.

Shehadeh M, Suaifan G, Darwish RM, Wazaify M, Zaru L, Alja'fari S. Shehadeh M, et al. Among authors: zaru l. Saudi Pharm J. 2012 Apr;20(2):125-33. doi: 10.1016/j.jsps.2011.11.005. Epub 2011 Dec 2. Saudi Pharm J. 2012. PMID: 23960783 Free PMC article.

10

Outcome of childhood acute lymphoblastic leukemia in Jordan.

Halalsheh H, Abuirmeileh N, Rihani R, Bazzeh F, Zaru L, Madanat F. Halalsheh H, et al. Among authors: zaru l. Pediatr Blood Cancer. 2011 Sep;57(3):385-91. doi: 10.1002/pbc.23065. Epub 2011 Feb 25. Pediatr Blood Cancer. 2011. PMID: 21360658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page